Frederic H. Moll, Director at Intersect ENT, Inc. (XENT), sold 800 shares at $29.00 ($23K) on 2017-11-10, disclosed to the SEC on 2017-11-14.
Open-market sale of $23k XENT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| SSII | BUY | 2025-02-24 | $10.0M | — | Filing → |
| SSII | BUY | 2025-01-10 | $4.0M | — | Filing → |
| SSII | BUY | 2025-01-03 | $6.0M | — | Filing → |